Use of preclinical models for malignant pleural mesothelioma. (2021)
Attributed to:
EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2020-216602
PubMed Identifier: 33692175
Publication URI: http://europepmc.org/abstract/MED/33692175
Type: Journal Article/Review
Volume: 76
Parent Publication: Thorax
Issue: 11
ISSN: 0040-6376